FIRST WAVE BIO, INC.

Profile

Company Names

FIRST WAVE BIO, INC.

Addresses

C/O COVINGTON + BURLING LLP, 620 EIGHTH AVENUE, NEW YORK, NY 10018-1405

Phone Numbers

734-546-0228

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$2,617,503.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-09-06 
$2,617,503.00 
$5,000,000.00 
$2,382,497.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
 
GLICK 
DIRECTOR
LYCERA CORP   |  IFM THERAPEUTICS, INC.   |  FIRST WAVE BIO, INC.   |  IFM QUATTRO, INC.   |  IFM CINQUE, INC.   |  IFM CONTINUA, INC.   |  SCORPION THERAPEUTICS, INC.   |  CHARM THERAPEUTICS INC.
DAVID 
 
HOFFMAN 
EXECUTIVE OFFICER, DIRECTOR
NEXT BIG SOUND INC   |  THRESHOLD PHARMACEUTICALS INC   |  ZEBRA IMAGING INC   |  EVENTSORBET, INC.   |  FLYNTLOK, INC.   |  HILDENE OPPORTUNITIES FUND LP   |  HILDENE OPPORTUNITIES FUND II, L.P.   |  FIRST WAVE BIO, INC.   |  HILDENE CREDIT FUND, LP   |  FIRST WAVE BIOPHARMA, INC.   |  DELCATH SYSTEMS, INC.   |  BVC DIGITAL OPPORTUNITIES I, LP   |  MARKETSAI CORP.
LEONARD 
 
OREMLAND 
DIRECTOR
FIRST WAVE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#